COMPANY

ADVANZ PHARMA CANADA INC.

ADVANZ PHARMA CANADA INC.: marketing authorisation holder for Lanreotide, as stated by public registers.

MARKETING AUTHORISATION HOLDER

Holds the licence to sell the medicine in a country (EMA, MHRA, Health Canada).

LanreotideMYTOLAC (DIN 02555867), Marketed Regulator Health Canada
LanreotideMYTOLAC (DIN 02555875), Marketed Regulator Health Canada
LanreotideMYTOLAC (DIN 02555883), Marketed Regulator Health Canada

What a register states, not an endorsement or an accusation by this site. All companies.

WEEKLY

Register Watch, weekly

New trials, approvals and enforcement actions. One email a week.